How much does tucatinib monthly treatment cost?

Tucatinib, also known as tucatinib, is a tyrosine kinase inhibitor that targets human epidermal growth factor receptor2 (HER2). It has shown significant effects in the treatment of refractory, advanced or metastatic HER2-positive breast cancer and colorectal cancer when combined with other anti-tumor drugs. As an anti-tumor drug, tucatinib ultimately achieves the goal of eliminating cancer cells by interfering with the growth process of cancer cells. However, because the drug may also affect normal cell growth, patients may experience varying degrees of adverse reactions during use, some of which may be serious and need to be reported to medical experts in a timely manner.

The dosage of tucatinib varies depending on the individual situation of the patient, and the dosage instructions on the doctor's instructions or drug instructions must be strictly followed. The dosage, frequency of taking, and length of treatment cycle are determined based on the patient's specific condition and the doctor's treatment plan.

For adult patients receiving trastuzumab in combination with capecitabine for the treatment of advanced or metastatic breast cancer and trastuzumab for the treatment of advanced or metastatic colorectal cancer, the recommended tucatinib dose is 300 mg twice daily. The doctor will adjust the dose based on the patient's needs and tolerance. Dosage and use in pediatric patients must be determined by a professional physician on a case-by-case basis.

On the market, tucatinib is mainly available in two packaging specifications: 150 mg in 30-capsule packaging and 150 mg in 60-capsule packaging. According to the recommended dosage, the 30-capsule package can meet half a month's medication needs, while the 60-capsule package is enough for one month's use. When selecting drug specifications and formulating a medication plan, patients should fully consider their personal circumstances and consult their doctors for advice.

Since tucatinib has not yet been marketed in China, it cannot be included in the scope of domestic medical insurance reimbursement. According to relevant information, the price of original research drugs on the market overseas is relatively high. A box of 150 mg and 60 pills costs as much as 72,000 yuan, which means that if a patient chooses the original research version of tucatinib for treatment, the monthly drug cost will reach 72,000 yuan.

Fortunately, there are more affordable generic drug options on the market. For example, produced by Everest Pharmaceuticals in BangladeshThe price of 150 mg 30-pellet medicine is 6,000 yuan per box, while the same specifications of medicines from Bangladesh Ziskar Pharmaceuticals are priced at 4,500 yuan per box. Therefore, when patients choose these two generic drugs for treatment, the monthly drug costs will be 12,000 yuan and 9,000 yuan respectively. In addition, the generic Tucatinib launched by Lucius Pharmaceuticals in Laos is also relatively cost-effective. The price of 150 mg of 60 tablets is about 3,600 yuan, which is also the cost of the drug for a patient for one month.

If patients have more questions about tucatinib or need further understanding, it is recommended to consult a regular overseas medical consulting company to obtain accurate and professional information.